Showing results (1791-1800 of 1,853) with videos related to
Sort By:
Pageof 186
Journal of Managed Care & Specialty Pharmacy|July 11, 2025
AMCP Market Insights: Payer best practices in food allergy managementTerry Richardson, Susan Wescott, Ruchi Gupta, et al.Journal of Managed Care & Specialty Pharmacy|June 3, 2025
Budget impact analysis of revumenib for the treatment of relapsed or refractory acute leukemias with a KMT2A translocation in the United StatesIvo Abraham, Pam Martin, Shailja Vaghela, et al.Journal of Managed Care & Specialty Pharmacy|May 30, 2025
Examining the relationship between adherence and the number of cardiometabolic medications: Findings for patients with type 2 diabetes within a Tribal health care systemTarah Nelson, Chasity Pierre, Yingwei Yao, et al.Journal of Managed Care & Specialty Pharmacy|March 31, 2024
Insights into insurance coverage for digital therapeutics: A qualitative study of US payer perspectivesAinhoa Gomez Lumbreras, Jason T Hurwitz, Xi Liang, et al.Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Cost-effectiveness of large-panel next-generation sequencing in guiding first-line treatment decisions for patients with nonsquamous advanced non-small cell lung cancerIbrahim M Abbass, Daniel M Sheinson, Anuj Shah, et al.Journal of Managed Care & Specialty Pharmacy|February 7, 2024
Medicare Part D low-income subsidies expanded in January 2024, but more needs to be done to ensure that eligible beneficiaries enrollF Ellen Loh, Bruce C Stuart, Rebecca J Hunt, et al.Journal of Managed Care & Specialty Pharmacy|February 3, 2024
Tirzepatide 10 and 15 mg vs semaglutide 2.0 mg: A long-term cost-effectiveness analysis in patients with type 2 diabetes in the United StatesReema Mody, William J Valentine, Meredith Hoog, et al.Journal of Managed Care & Specialty Pharmacy|February 3, 2024
A systematic review of the real-world effectiveness and economic and humanistic outcomes of selected oral antipsychotics among patients with schizophrenia in the United States: Updating the evidence and gapsKi Jin Jeun, Khalid M Kamal, Keyuri Adhikari, et al.Journal of Managed Care & Specialty Pharmacy|February 3, 2024
Biosimilar perceptions among autoimmune prescribers and pharmacists in health system specialty pharmacyCarly Giavatto, Jessica Mourani, Casey Fitzpatrick, et al.Journal of Managed Care & Specialty Pharmacy|August 30, 2024
Manufacturer-sponsored drug coupon use and drug-switching behavior among patients with type 2 diabetesYang Wang, So-Yeon Kang, Mariana P Socal, et al.Pageof 186